AURKA and cancer: In the present study, we designed and synthesized a novel quinazolin-4(3H)-one derivative, BIQO-19, with improved solubility and pharmacokinetic properties and which exhibits increased antiproliferative activity against cancer cells with aurora kinase A inhibition.